Ticker
TNXPCompany Name
TONIX PHARMACEUTICALS HOLDING CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 187.36M | $ 125.33M | 66.89% |
3/31/2025 | $ 192.87M | $ 131.72M | 68.29% |
12/31/2024 | $ 162.89M | $ 98.78M | 60.64% |
9/30/2024 | $ 94.99M | $ 28.23M | 29.72% |
6/30/2024 | $ 70.31M | $ 4.16M | 5.91% |
3/31/2024 | $ 135.34M | $ 7.05M | 5.21% |
12/31/2023 | $ 154.46M | $ 24.95M | 16.15% |
9/30/2023 | $ 139.28M | $ 6.91M | 4.96% |
6/30/2023 | $ 159.74M | $ 25.62M | 16.04% |
3/31/2023 | $ 179.09M | $ 71.97M | 40.19% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: CashnEq [ $ 55.9M ] / Assets [ $ 67.62M ]
(=) Cash to Assets [ 82.67% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |